title: [Chronotherapy combining 5-fluorouracil, folinic acid and carboplatin as first line treatment in metastatic colorectal cancer. A phase 2 study].
abstract: Seventy-two patients suffering from a metastatic colorectal cancer received, as first line treatment, a combination chronotherapy with 5-FU and folinic acid (infused from 10 pm to 10 am with a peak at 4 am, respectively at doses of 700 and 300 mg/m2 per day) and carboplatin (infused at the dose of 40 mg/m2 per day from 10 am to 10 pm with a peak at 4 pm). The courses of four days were repeated every two weeks. A major tumoral response was observed in 60% cases (68% in those not previously treated with adjuvant chemotherapy). The median times to progression and overall survival established at 11 and 27 months. The clinical (grades 3-4 in maximum 5% cases) and hematological (grades 3-4 in maximum 10-29% cases) toxicities were quite limited. Our observations suggest the interest to incorporate carboplatin in the combined infusional treatment of colorectal cancer.
authors.affiliation: Département d'oncologie médicale CHC, clinique Saint-Joseph, rue de Hesbaye 75, 4000 Liège, Belgique. christian.focan@CHC.be
authors.forename: C
authors.initials: C
authors.lastname: Focan
authors.forename: F
authors.initials: F
authors.lastname: Kreutz
authors.forename: L
authors.initials: L
authors.lastname: Longrée
authors.forename: M P
authors.initials: MP
authors.lastname: Graas
authors.forename: D
authors.initials: D
authors.lastname: Focan-Henrard
authors.forename: N
authors.initials: N
authors.lastname: Moeneclaey
authors.forename: A
authors.initials: A
authors.lastname: David
authors.forename: J F
authors.initials: JF
authors.lastname: Biquet
authors.forename: R
authors.initials: R
authors.lastname: Materne
authors.forename: J
authors.initials: J
authors.lastname: Weerts
authors.forename: M
authors.initials: M
authors.lastname: Delforge
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use* / Q000633:toxicity; D016190:Carboplatin / Q000008:administration & dosage* / Q000633:toxicity; D002909:Chronobiology Phenomena; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000633:toxicity; D006801:Humans; D007262:Infusions, Intravenous; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012004:Rectal Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D016019:Survival Analysis
chemical_list: D016190:Carboplatin; D002955:Leucovorin; D005472:Fluorouracil